These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4648995)

  • 21. Isolation of a bovine Theileria.
    Kuttler KL; Craig TM
    Am J Vet Res; 1975 Mar; 36(3):323-5. PubMed ID: 804831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitory effect of imidocarb on experimental anaplasmosis in splenectomized calves.
    Roby TO
    Res Vet Sci; 1972 Nov; 13(6):519-22. PubMed ID: 4648992
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy to eliminate Anaplasma marginale under field and laboratory conditions.
    Kuttler KL; Johnson LW; Simpson JE
    Proc Annu Meet U S Anim Health Assoc; 1980; 84():73-82. PubMed ID: 6947300
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunity in bovine anaplasmosis after elimination of anaplasma marginale infections with imidocarb.
    Roby TO; Amerault TE; Mazzola V; Rose JE; Ilemobade A
    Am J Vet Res; 1974 Jul; 35(7):993-5. PubMed ID: 4842856
    [No Abstract]   [Full Text] [Related]  

  • 25. Anaplasma marginale infection in splenectomized calves.
    Jones EW; Norman BB; Kliewer IO; Brock WE
    Am J Vet Res; 1968 Mar; 29(3):523-33. PubMed ID: 5637919
    [No Abstract]   [Full Text] [Related]  

  • 26. A preliminary evaluation of a dithiosemicarbazone for the treatment of anaplasmosis.
    Kuttler KL; Zaraza H
    Res Vet Sci; 1970 Jul; 11(4):334-8. PubMed ID: 5499316
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of three oxytetracycline regimes for the treatment of persistent Anaplasma marginale infections in beef cattle.
    Coetzee JF; Apley MD; Kocan KM; Rurangirwa FR; Van Donkersgoed J
    Vet Parasitol; 2005 Jan; 127(1):61-73. PubMed ID: 15675047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The elimination of Anaplasma marginale from carrier cattle by treatment with long acting oxytetracycline.
    Rogers RJ; Dunster PJ
    Aust Vet J; 1984 Sep; 61(9):306. PubMed ID: 6517790
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of dexamethasone on the recrudescence of Anaplasma marginale in splenectomized calves.
    Kuttler KL; Adams LG
    Am J Vet Res; 1977 Sep; 38(9):1327-30. PubMed ID: 921027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of apparent suppression of Anaplasma marginale infection by eperythrozoonosis (Eperythrozoon teganodes).
    Hadani A; Guglielmone AA; Anziani OS; Tarablas H; Mangold A; Bermudez A; Castor JC; Gonzalez de Rios L
    Vet Parasitol; 1982 Feb; 9(3-4):267-72. PubMed ID: 6211820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimentally induced anaplasmosis in neonatal isohemolytic anemia-recovered calves.
    Young MF; Kuttler KL; Adams LG
    Am J Vet Res; 1977 Nov; 38(11):1745-7. PubMed ID: 563204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of an experimental long-acting oxytetracycline (Terramycin/LA) in the treatment of acute anaplasmosis.
    Kuttler KL; Young MF; Simpson JE
    Vet Med Small Anim Clin; 1978 Feb; 73(2):187-92. PubMed ID: 245908
    [No Abstract]   [Full Text] [Related]  

  • 34. Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures.
    Coetzee JF; Apley MD; Kocan KM; Jones DE
    J Vet Pharmacol Ther; 2006 Jun; 29(3):173-83. PubMed ID: 16669861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-ethoxyethylglyoxal dithiosemicarbazone in the treatment of field cases of anaplasmosis.
    Castillo A; Martinez J
    Trop Anim Health Prod; 1972; 4(3):138-41. PubMed ID: 4671462
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.
    Magonigle RA; Simpson JE; Frank FW
    Am J Vet Res; 1978 Sep; 39(9):1407-10. PubMed ID: 697150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to anaplasmosis after elimination of latent Anaplasma marginale infections.
    Richey EJ; Brock WE; Kliewer IO; Jones EW
    Am J Vet Res; 1977 Feb; 38(2):169-70. PubMed ID: 557302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of gloxazone, an effective but toxic anaplasmacide, with imidocarb dihydrochloride.
    McHardy N; Berger J; Taylor RJ; Farebrother D; James JA
    Res Vet Sci; 1980 Sep; 29(2):198-202. PubMed ID: 6451008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprophylaxis of vector-borne anaplasmosis with sustained-release boluses.
    byford RL; Riner JL; Kocan KM; Stratton LG; Hair JA
    Am J Vet Res; 1981 Dec; 42(12):2088-9. PubMed ID: 7340579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrastructural and fluorochromatic changes of Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures.
    Coetzee JF; Kocan KM; Higgins JJ; Apley MD; Jones DE
    Vet Microbiol; 2009 Apr; 136(1-2):45-53. PubMed ID: 19054634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.